76.65MMarket Cap-1212P/E (TTM)
1.650High1.350Low14.63KVolume1.350Open1.330Pre Close22.19KTurnover3.00052wk High0.06%Turnover Ratio47.90MShares1.33052wk Low-1.32EPS TTM39.69MFloat Cap3.800Historical HighLossP/E (Static)24.81MShs Float1.330Historical Low-1EPS LYR22.56%Amplitude--Dividend TTM0.56P/B1Lot Size--Div YieldTTM
Palisades Goldcorp Ltd Stock Forum
Palisade Bio, Inc. (Nasdaq: PALI), a biopharmaceutical firm dedicated to developing innovative therapeutics for autoimmune, inflammatory, and fibrotic diseases, has provided an update on its collaboration with Strand Life Sciences ("Strand"), a prominent bioinformatics specialist. This partnership is focused on enhancing precision medicine for ulcerative colitis (UC)...
No comment yet